Health ❯Cardiovascular Health

Cardiovascular Disease

Risk Factors Arterial Inflammation Heart Disease Mortality Causes GLP-1/GIP Agonists Mortality Rates

Dual Brain Receptor Targeting Shows Promise for Enhanced Obesity Treatment

A novel peptide–antibody conjugate demonstrates additive weight loss effects by simultaneously activating GIPR and GLP-1R in the brain.

FDA Approves Ozempic to Reduce Kidney Disease Risks in Type 2 Diabetes Patients

Diabetes and Obesity Drugs Found to Protect Kidney Health

Study Links Aerobic Fitness to Lower Dementia Risk